Skip to main content
Premium Trial:

Request an Annual Quote

In LoBosco’s World, All Software Is Enticing

Premium

For Rob LoBosco, it seems there’s no IT problem that isn’t intriguing. His latest challenge comes in the form of Seattle-based Life- Span BioSciences, where he’s the new chief information officer. He’ll be in charge of building the IT infrastructure for the company, as well as choosing “the right technologies and platforms” to keep it heading in a positive direction while anticipating the growth in the pharma and biotech industry.

LifeSpan, which currently has about 150 employees, sells various versions of its drug target database. According to LoBosco, 35, smaller biotechs usually buy a portal that includes GPCR targets, while pharmas get a more comprehensive package that also has gene families and antibodies.

LoBosco’s pharma experience comes from a few years at Merck’s IT department. “The Merck experience introduced me to a very large company dealing with a global environment and a very large IT budget,” he says. He left in 1999 “to work on some of the dot-coms that were starting at the time,” he says — including HotJobs — ruefully adding that one or two “became dot-bombs.”

Previously, he worked on satellite programs for NASA. But LoBosco’s software engineering career began at Sikorsky Aircraft, which he joined as a junior in college and stayed at after graduation. He primarily worked on helicopter simulation programs: “much like very large, very expensive video games,” he says.

— Meredith Salisbury

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.